Drug intelligence / Profile preview

CTC-96

Development stage
Unknown
Lead developer
OPKO Health
Modality
DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Topical, Ophthalmic
01

Overview

CTC-96 is a small molecule metallo-organic compound known as a cobalt(III) Schiff base chelate. It has demonstrated potent antiviral and anti-inflammatory properties in both in vitro and in vivo studies. The drug acts primarily by inhibiting free radicals and blocking essential enzymes required for viral replication. Mechanistically, it functions as an inhibitor of membrane fusion events during the life cycle of enveloped viruses, thereby preventing viral entry into host cells. CTC-96 has shown efficacy against herpes simplex virus (HSV), adenovirus type 5 (Ad5), varicella-zoster virus (VZV), and vesicular stomatitis virus (VSV). Its primary indications are infectious diseases affecting the eye—such as keratoconjunctivitis—and skin/musculoskeletal diseases[1][2][3][4][6][8].

Brand names
DoxovirDoxovir-L
Other names
cobalt chelate complex CTC-96Co(III) chelatemetallo-organic cobalt Schiff base complex
02

Targets

HMPV F (Human metapneumovirus fusion protein)

Beyond the preview

Go deeper on CTC-96.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CTC-96.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call